Merck's actions surrounding Vioxx.
Heinley
Michael
M
D000329:Advertising / Q000941:ethics / Q000379:methods; D026688:Bioethical Issues; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects*; D004345:Drug Industry / Q000941:ethics / Q000379:methods; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D009203:Myocardial Infarction / Q000209:etiology; D013450:Sulfones / Q000009:adverse effects*
D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib